Flexible trial designs may help companies make earlier decisions, reduce drug development costs and to shorten the amount of time needed to bring a drug to market. An increasing number of pharmaceutical companies are using these adaptive designs in confirmatory trials with successful results. Hear about these new techniques and other clinical trial advancements at IBC’s 3rd International Adaptive Designs for Clinical Trials. The conference will be held May 10-11, 2007 at the Royal Sonesta Hotel Boston
in Cambridge, Massachusetts.

Learn the latest industry trends by attending the keynotes.

Michael Krams, M.D., Assistant Vice President, Adaptive Trials, Clinical Development, at Wyeth will present the State of the Adaptive Design Industry.

Richard Simon, D.Sc., Chief, Biometric Research Branch, with the National Cancer Institute will give insight to new adaptive designs with Use of Adaptive Analysis Plans and Seamless Phase II/III Designs in
Pharmacogenomic Biomarker Based Clinical Trials.

For detailed conference information, download the brochure at
http://www.ibclifesciences.com/d3216.

To register, contact our Client Services Department at 800-390-4078 or visit the conference web site today.

Deb Fowler-Clare
Senior Conference Producer
IBC Life Sciences

PS. Register by March 16 & Save $200!

TO REGISTER

Online: http://www.IBCLifeSciences.com/d3216
Call: 800.390.4078
Fax: 941.365.0104
Email: reg@ibcusa.com
Priority Code: ZXPQYGY